Rapport Therapeutics, Inc. · NASDAQ:RAPP

Yeleswaram Krishnaswamy sold 19,865 Rapport Therapeutics, Inc. shares (Form 4)

Traded Apr 10 to Apr 14, 2026 · Filed Apr 14, 2026

From Apr 10 to Apr 14, 2026, Yeleswaram Krishnaswamy (Chief Development Officer) sold 19,865 Rapport Therapeutics, Inc. shares at an average US$35.03 for US$696K under a trading plan, leaving 266,651 shares. Filed Apr 14, 2026 (Form 4).

Sold
19,865 shares
Price
US$35.03 average (US$34.97 to US$35.08)
Value
US$696K
Holding after
266,651 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 10, 2026Common StockSale500US$34.98286,016Direct
Apr 13, 2026Common StockSale9,165US$34.97276,851Direct
Apr 14, 2026Common StockSale10,200US$35.08266,651Direct

Source

View original at SEC

Related